EFFICACY AND TOLERABILITY OF BEVACIZUMAB MONOTHERAPY IN PATIENTS WITH PREVIOUSLY TREATED RECURRENT GLIOBLASTOMA MULTIFORME (GBM)

被引：0
|
作者：
Francini, E. [1 ]
Mazzaroppi, S. [1 ]
Salvati, M. [2 ]
Caponnetto, S. [1 ]
Laera, L. [3 ]
Migali, C. [3 ]
Bianco, V. [1 ]
机构：
[1] Univ Roma La Sapienza, Policlin Umberto Hosp 1, Oncol Unit, I-00185 Rome, Italy
[2] Univ Roma La Sapienza, Policlin Umberto Hosp 1, Dept Med Surg Sci & Biotechnol, I-00185 Rome, Italy
[3] Univ Siena, Policlin Santa Maria Scotte Hosp, Dept Med Oncol, I-53100 Siena, Italy
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P17.32
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase II trial of lapatinib and pazopanib for patients with recurrent glioblastoma multiforme (GBM)
    Reardon, David
    Groves, Morris
    Wen, Patrick
    Nabors, Louis
    Mikkelsen, Tom
    Rosenfeld, Steve
    Harris, Dean
    DeMarini, Douglas
    Suttle, Ben
    Arumugham, Thangam
    Hodge, Jeffrey
    Lager, Joanne
    [J]. NEURO-ONCOLOGY, 2007, 9 (04) : 516 - 516
  • [32] Patterns of progression in patients with recurrent glioblastoma treated with bevacizumab
    Pope, W. B.
    Xia, Q.
    Paton, V. E.
    Das, A.
    Hambleton, J.
    Kim, H. J.
    Huo, J.
    Brown, M. S.
    Goldin, J.
    Cloughesy, T.
    [J]. NEUROLOGY, 2011, 76 (05) : 432 - 437
  • [33] Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab
    Wefel, Jeffrey S.
    Cloughesy, Timothy
    Zazzali, James L.
    Zheng, Maoxia
    Prados, Michael
    Wen, Patrick Y.
    Mikkelsen, Tom
    Schiff, David
    Abrey, Lauren E.
    Yung, W. K. Alfred
    Paleologos, Nina
    Nicholas, Martin K.
    Jensen, Randy
    Vredenburgh, James
    Das, Asha
    Friedman, Henry S.
    [J]. NEURO-ONCOLOGY, 2011, 13 (06) : 660 - 668
  • [34] Prognostic factors in recurrent glioblastoma patients treated with bevacizumab
    Schaub, Christina
    Tichy, Julia
    Schaefer, Niklas
    Franz, Kea
    Mack, Frederic
    Mittelbronn, Michel
    Kebir, Sied
    Thiepold, Anna-Luisa
    Waha, Andreas
    Filmann, Natalie
    Banat, Mohammed
    Fimmers, Rolf
    Steinbach, Joachim P.
    Herrlinger, Ulrich
    Rieger, Johannes
    Glas, Martin
    Baehr, Oliver
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2016, 129 (01) : 93 - 100
  • [35] Prognostic factors in recurrent glioblastoma patients treated with bevacizumab
    Christina Schaub
    Julia Tichy
    Niklas Schäfer
    Kea Franz
    Frederic Mack
    Michel Mittelbronn
    Sied Kebir
    Anna-Luisa Thiepold
    Andreas Waha
    Natalie Filmann
    Mohammed Banat
    Rolf Fimmers
    Joachim P. Steinbach
    Ulrich Herrlinger
    Johannes Rieger
    Martin Glas
    Oliver Bähr
    [J]. Journal of Neuro-Oncology, 2016, 129 : 93 - 100
  • [36] Phase II study to evaluate the clinical efficacy and safety of MEDI4736 (durvalumab) in patients with glioblastoma (GBM): Results for cohort B (durvalumab monotherapy), bevacizumab-naive patients with recurrent GBM
    Reardon, David A.
    Kaley, Thomas
    Dietrich, Jorg
    Lim, Michael
    Dunn, Gavin P.
    Gan, Hui K.
    Cloughesy, Timothy
    Clarke, Jennifer L.
    Park, Andrew
    Macri, Mary
    Ryan, Aileen
    Ricciardi, Toni
    Reddy, Vijay
    Venhaus, Ralph
    [J]. CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [37] Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients
    J. N. Jakobsen
    T. Urup
    K. Grunnet
    A. Toft
    M. D. Johansen
    S. H. Poulsen
    I. J. Christensen
    A. Muhic
    H. S. Poulsen
    [J]. Journal of Neuro-Oncology, 2018, 137 : 439 - 446
  • [38] Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients
    Jakobsen, J. N.
    Urup, T.
    Grunnet, K.
    Toft, A.
    Johansen, M. D.
    Poulsen, S. H.
    Christensen, I. J.
    Muhic, A.
    Poulsen, H. S.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2018, 137 (02) : 439 - 446
  • [39] A pilot study to assess the tolerability and efficacy of RAD-001 (everolimus) with gefitinib in patients with recurrent glioblastorna multiforme (GBM).
    Nguyen, T. D.
    Lassman, A. B.
    Lis, E.
    Rosen, N.
    Shaffer, D. R.
    Scher, H. I.
    Deangelis, L. M.
    Abrey, L. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 59S - 59S
  • [40] Safety and efficacy of carboplatin monotherapy dosed utilizing the Calvert formula in recurrent glioblastoma multiforme
    Glass, Jon
    [J]. NEURO-ONCOLOGY, 2006, 8 (04) : 443 - 443
12345